AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding AbCellera Biologics Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 129 | 2 | 128 | +1 |
| Shares | 125.4M | 7.61K | 107.6M | ā17.7M (ā14.1%) |
| Value | $280.1M | $17.0K | $370.6M | +$90.5M (+32.3%) |
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held AbCellera Biologics Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Driehaus Capital Management LLC | 499,922 | $1.71M | 0.01% |
| Polar Asset Management Partners Inc. | 159,800 | $548.1K | 0.01% |
| Graham Capital Management, L.P. | 143,035 | $490.6K | 0.01% |
| Jane Street Group, LLC | 93,980 | $322.4K | 0.00% |
| Prelude Capital Management, LLC | 64,813 | $222.3K | 0.02% |
| D. E. Shaw & Co., Inc. | 51,074 | $175.2K | 0.00% |
| State of Michigan Retirement System | 49,225 | $168.8K | 0.00% |
| Headlands Technologies LLC | 37,795 | $129.6K | 0.02% |
| Commonwealth Equity Services, LLC | 36,427 | $125.0K | 0.00% |
| XML Financial, LLC | 34,500 | $118.3K | 0.01% |
| Ballentine Partners, LLC | 23,689 | $81.3K | 0.00% |
| Marex Group plc | 20,000 | $68.6K | 0.00% |
| LPL Financial LLC | 18,224 | $62.5K | 0.00% |
| Lantern Wealth Advisors, LLC | 15,000 | $51.5K | 0.03% |
| J2 Capital Management Inc | 13,100 | $44.9K | 0.04% |
| Caitong International Asset Management Co., Ltd | 10,127 | $34.7K | 0.02% |
| Mount Yale Investment Advisors, LLC | 1,905 | $6.53K | 0.00% |
| MAI Capital Management | 1,018 | $3.49K | 0.00% |
| Skopos Labs, Inc. | 177 | $608 | 0.00% |
Sold out (18)
Institutions that held AbCellera Biologics Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Voya Investment Management LLC | 10,624,185 | $23.7M |
| Prosight Management, LP | 2,815,652 | $6.28M |
| PDT Partners, LLC | 64,304 | $143.4K |
| Jain Global LLC | 54,918 | $122.5K |
| Centiva Capital, LP | 46,621 | $104.0K |
| Oxford Asset Management LLP | 28,241 | $63.0K |
| Allianz Asset Management GmbH | 25,622 | $60.5K |
| Clarkston Capital Partners, LLC | 22,000 | $49.1K |
| Quadrant Capital Group LLC | 21,946 | $48.9K |
| IMG Wealth Management, Inc. | 19,000 | $42.4K |
| SIH Partners, LLLP | 17,163 | $38.3K |
| AssuredPartners Investment Advisors, LLC | 15,356 | $34.2K |
| Quadrature Capital Ltd | 14,584 | $32.4K |
| Stratos Wealth Advisors, LLC | 12,000 | $26.8K |
| Evergreen Capital Management LLC | 11,633 | $25.9K |
| Mariner, LLC | 10,966 | $24.5K |
| Rhumbline Advisers | 135 | $301 |
| Continuum Advisory, LLC | 93 | $207 |
Not filed for Q2 2025 yet (2)
Institutions that held AbCellera Biologics Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Credit Agricole S A | 6,600 | $14.7K |
| Lindbrook Capital, LLC | 1,011 | $2.25K |